Skip to main content

Maintain supply of knee implants, govt tells firms

By
Maintain supply of knee implants, govt tells firms
The government on tuesday made it manadatory for knee implant manufactures and importers to maintain production and supply of knee implants by invoking an emergency clause under the derug price control law.
The department of pharmeuticals (DoP) under the ministry of chemicals and fertilizers invoked powers under the Drugs (Prices Control) Order, 2013, to mandate firms to continue the saler iof knee implants without interruption, following the recent price capping on knee impants. DoP, in its order posted on its websitre on Tuesday, directed firms to submit a weekly report on "distributuion and "production"of knee implant systems.

The National Pharmaceutical Pricing Authority (NPPA) had in August reduced the average price for knee impant by as mych as 69%.According to notification issued by the price regulator, the most widely used complete knee implant (Cobalt Chromium) now costs Rs 54,720 plus GST, gainst Rs 1.58 lakh earlier.
NPPA also capped the price of a second surgery to Rs 1.3 lakh against Rs 2.76 lajkh earlier. Prices of Specil metals such as Titanium and Oxidised Ziorconium were also capped at Rs 76,600 (prices of these were not capped earlier: they used to cost Rs 2.49 lakh). The government has asked manufacturers to maintain production important supply of Orthopedic knee implant system that existed before august then the price caps weere announced under section 3 (i) of DPCO, 2013 The government can regulate distribution in direct any manufacturer tidays production and sale products to institution hospitals or any agency may be in case of emergency or in circumstances urgencfy or in case of non-commercial use of public interest

With the view to acheive adequate availability and regulate distribvution of drug in case of emergency or in circumstances of urgency or in caswe of non-commercuia use in public interestdirect any manufacturer of any active farmer suitable ingredient or drug or formulation to increse production into direct formulaters to serve the formulation to institutions,hospitals or any agency,"Dop said in its order .

Additionally,the companies are also directed to furnish the production figures from 2015 to 2017-2018. The move will ensure uninterrupted supply of knee implant by the manufacturers and importer.NPPA can take action against the company in case it receives any complaint of shortage or the company is charging a higher price ," said an official requesting anonymity.

The Mint, New Delhi, 27th September 2017

Comments

Post a Comment

Popular posts from this blog

Govt’s gamble on GST cuts: What do the bond and currency markets signal?

By
  It’s not just humans who suffer from cognitive biases; markets do too. Interestingly, different financial markets exhibit distinct biases, each interpreting events through its own prism of prejudice. Take the recent announcements on GST reforms: equity markets have chosen to view them through the lens of growth, while bond and currency markets are focusing on potential macroeconomic risks—fiscal pressures and current account challenges. So, which lens captures the true pulse?Equity markets may be right in expecting GST reforms to revive consumption, which has remained lacklustre for a while. But the key question remains—will this revival come at the cost of broader macro stability?It is well known that consumption stocks have rallied since the GST rationalisation announcement. But what about bond markets? What signals are they sending since this rejig was announced from the ramparts of the Red Fort?The signs aren't encouraging. Bond prices have slumped and yields have surged sinc...
Post a Comment
Read more

Luxury carmakers urge clarity on GST rates to boost festive season sales

By
  A clear picture regarding new GST rates at the earliest will help the overall auto industry, including the luxury car segment, to regain momentum in the ongoing quarter, which generally sees enhanced sales on account of the festive season.The high-powered GST Council, chaired by Finance Minister Nirmala Sitharaman, will meet on September 3-4 to discuss moving to a two-slab taxation.In an interaction with PTI, BMW Group India President and CEO Hardeep Singh Brar said the recent speculation about the change in GST rates has caused uncertainty in the minds of consumers.Consumer interest and demand is strong, but they (prospective buyers) have adopted a wait-and-watch approach, and this delayed decision-making is impacting new vehicle sales at a certain level, he noted."Expediting clarity on GST rates is essential to get back to speed and ensure the auto sector's contribution to economic growth during this quarter is robust," Brar stated.He also hoped that the sustainable p...
Post a Comment
Read more

Sebi proposes tighter norms for green bond third-party reviewers

By
  Sebi on Friday said it has proposed to tighten the norms to appoint independent third-party reviewers or certifiers for green debt securities to align them with requirements for other ESG-linked bonds.In a draft circular, Sebi said that the current norms for green bonds, introduced in February 2023, lack detailed requirements around reviewer independence, conflict of interest mitigation, and disclosure standards that are now in place for other ESG-linked securities under a June 2025 circular.The regulator's latest proposal seeks public comments on a revised framework that would bring parity by incorporating comprehensive criteria for third-party certifiers of green bonds on non-convertible securities.Under the proposed norms, issuers of green debt securities will need to appoint reviewers who are independent of their management, directors, and key managerial personnel. These reviewers will be remunerated in a way that prevents any conflicts of interest and possess relevant expert...
Post a Comment
Read more